EGF and adenocarcinoma: For instance, in adenocarcinoma cells, acute exposure to dexamethasone inhibited epidermal growth factor (EGF)-induced arachidonic acid release, a key inflammation mediator, through a GR-dependent (RU486-sensitive) and transcription-independent (actinomycin D-insensitive) mechanism [27].